Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Authors
Karen Eggleston
News Type
News
Date
Paragraphs

China’s recent initiatives to deepen health reform, control antimicrobial resistance, and strengthen primary health services are the topics of ongoing collaborative research by the Asia Health Policy Program (AHPP) at Stanford’s Shorenstein Asia-Pacific Research Center and Chinese counterparts. For example, with generous support from ACON Biotechnology and in partnership with the ACON Biotech Primary Care Research Center in Hangzhou, China, AHPP hosts an annual conference on community health services and primary health care reform in China.

The conference, titled Forum on Community Health Services and Primary Health Care Reform, was held in June at the Stanford Center at Peking University (SCPKU) in Beijing. It featured distinguished policymakers, providers and researchers who discussed a wide-range of topics from China’s emerging “hierarchical medical system” for referring patients to the appropriate level of care (fenji zhenliao), as well as the practice and challenges of innovative approaches to primary care and integrated medical care systems. Yongquan Chen, director of Yong’an City Hospital and representative for the mayor’s office of Sanming, talked about health reforms in Sanming City, Fujian Province, a famous example within China. He discussed the incentives and reasoning behind the reforms, which focus on removing incentives for over-prescription of medications, demonstrating government leadership for comprehensive reforms, consolidating three agencies into one, monitoring implementation and easing tensions between doctors and patients. He pointed out the feasibility and early successes of reform by comparing public hospitals in the city in terms of their revenues and costs, reduced reliance on net revenue from medication sales, and other dimensions of performance. Finally, he addressed reform implementation and future plans on both the hospital's and the government's part.

Xiaofang Han, former director of the Beijing Municipal Development and Reform Commission, shared her personal views on the challenges patients face in navigating China’s health system (kan bing nan) and the need to improve the structure of the delivery system, including a revision to the incentives driving over-prescription in China’s fee-for-service payment system. She emphasized that patients’ distrust of primary care providers can only be overcome by demonstrating improved quality (e.g. with a systematic training program for general practitioners, GPs), and that referral systems should be based on the actual capabilities of the clinicians, not their formal labels. To reach China’s goal of over 80 percent of patients receiving management and first-contact care within their local communities will require improved training and incentive programs for newly-minted MDs, a more flexible physician labor market, and innovations in e-health and patient choice regarding gatekeeping or “contract physician services” (qianyue fuwu).        

Guangde County People's Hospital Director Mingliang Xu spoke about practices and exploration of healthcare alliances and initiatives to provide transparent incentives linking medical staff bonuses to metrics of quality. Ping Zhu from Community Healthcare Service Development and Research Center in Ningbo addressed building solid relationships between doctors and residents and providing more patient-centered services.        

Professor Yingyao Chen from Fudan University School of Public Health discussed performance assessment of community health service agencies based on his research in Shanghai. He introduced the strengths and weaknesses of the incentives embedded in the assessment system for China’s primary care providers, and concluded with suggestions for future research. Dr. Linlin Hu, associate professor at Peking Union Medical College, discussed China's progress and challenges of providing universal coverage of national essential public health services.

Professor Hufeng Wang of Renmin University of China discussed China’s vision for a “hierarchical medical system”– bearing resemblance to “integrated care,” “managed care,” or NHS-like coordination of primary and specialized care – with examples of pilot reforms from Xiamen, Zhenjiang and Dalian cities. Dr. Zuxun Lu, professor of Tongji Medical College of Huazhong University of Science and Technology, also discussed hierarchical medical systems and declared that China currently had a “discounted gatekeeper system.”

Dr. Yaping Du of Zhejiang University presented his research on mobile technology for management of lipid levels and with the help of a volunteer, demonstrated “Dyslipidemia Manager,” a mobile app-based product for both patients and doctors. Innovative strategies for primary prevention of cardiovascular diseases in low- and middle-income countries were the focus of remarks by Dr. Guanyang Zou from the Institute for Global Health and Development at Queen Margaret University, including its connections to international experiences with China’s current efforts in that area.  

In sum, the 2016 Forum elicited lively, evidence-based discussions about the opportunities and challenges in improving primary care and sustaining universal coverage for China.  Plans are underway for convening the third annual ACON Biotech-Stanford AHPP Forum on Community Health Services and Primary Health Care Reform in June 2017 at SCPKU. Anyone with original research or innovative experiences with primary care in China may contact Karen Eggleston regarding participation in next year’s Forum. 

Hero Image
groupphotoscpku062216
Policymakers, healthcare providers and researchers gathered at Stanford Center at Peking University to discuss community health services and primary healthcare reform, Beijing, June 2016.
All News button
1
-

Wei Huang uses the experience of China's One Child Policy to examine how fertility restrictions affect economic and social outcomes over the lifetime. The One Child Policy imposed a birth quota and heavy penalties for “out-of-plan” births. Using variation in the fertility penalties across provinces over time, He examines how fertility restrictions imposed early in the lives of individuals affected their educational attainment, marriage and fertility decisions, and later life economic outcomes. Exposure to stricter fertility restrictions when young leads to higher education, more white-collar jobs, delayed marriage, and lower fertility. Further consequences include higher household income, consumption, and saving. Finally, exposure to stricter fertility restrictions in early life increases female empowerment as measured by an increase in the fraction of households headed by women, female-oriented consumption and gender-equal opinions. Overall, fertility restrictions imposed when agents are young have powerful effects throughout the life cycle.

Image
Wei Huang is a Post-doctoral Fellow in Aging and Health Economics at the National Bureau of Economic Research. His main research studies public economics, labor economics, and health economics. He is interested in the topics such as health, education, ethnicity, and China. Wei received his PhD in economics from Harvard University in 2016. He received an M.A in economics from National School of Development at Peking University in 2011, and a B.A. in physics from School of Physics at Peking University in 2008.

 

Wei Huang Post-doctoral Fellow in Aging and Health Economics, the National Bureau of Economic Research
Seminars

 

Dr. Cohen is the Associate Vice Chancellor for Global Health, and the Yeargan-Bate Distinguished Professor of Medicine in Microbiology and Immunology, and Epidemiology at University of North Carolina. He received his BS from the University of Illinois, Urbana, and MD from the Rush Medical College. His research focuses on the transmission and prevention of transmission of STD pathogens including HIV. Much of his work has been conducted at the research sites he and his group have developed in Lilongwe, Malawi and Beijing, China. Dr. Cohen and his coworkers have identified the concentration of HIV in genital secretions required for transmission of HIV, and the effects of genital tract inflammation on HIV. Dr. Cohen is currently studying Zika as a sexually transmitted disease.

For registration, please send your name, affiliation, phone number and event name to: sanjiu39@stanford.edu

 

 

Stanford Center at Peking University, The Lee Jung Sen Building, Langrun Yuan, Peking University

 

Myron Cohen Associate Vice Chancellor for Global Health University of North Carolina
Lectures
-

 

Professor Khosla is the recipient of multiple distinguished awards including the Arthur C. Cope Scholar Award (2009) and Pure Chemistry Award (2000) of the American Chemical Society, and the Alan T. Waterman Award of the National Science Foundation (1999).

In addition to his role as the founding Director of Stanford ChEM-H, he serves on the Board of Directors of Protagonist Therapeutics (PTGX) and is a member of the Scientific Policy Committee of the SLAC National Accelerator Laboratory. His laboratory research focuses on problems where deep insights into enzymology and metabolism can be harnessed to improve human health. 

For registration, please send your name, affiliation, number and event title to: sanjiu39@stanford.edu 

 

The Lee Jung Sen Building, Langrun Yuan, Peking University

 

CHAITAN KHOSLA Director, Stanford ChEM-H, and Wells H. Rauser and Harold M. Petiprin Professor, School of Engineering; Professor of Chemistry, and, by courtesy, of Biochemistry Stanford University
Lectures
-

Vast amounts of molecular data characterizing the genome, epi-genome and transcriptome are becoming available for a wide range of cancers. In addition, new computational tools for quantitatively analyzing medical and pathological images are creating new types of phenotypic data.  Now we have the opportunity to integrate the data at molecular, cellular and tissue scale to create a more comprehensive view of key biological processes underlying cancer. This integration can have profound contributions toward predicting diagnosis and treatment. Prof. Gevaert will discuss current work in progress to tackle challenges in biomedical multi-scale data fusion. Olivier Gevaert is an assistant professor at Stanford University focusing on developing machine-learning methods for biomedical decision support from multi-scale biomedical data. 

For registration, please send your name, affiliation, number and event title to: sanjiu39@stanford.edu

 

 

The Lee Jung Sen Building, Langrun Yuan, Peking University.

Please bring a photo ID and enter Peking University through the NE Gate.  

Olivier Gevaert Assistant Professor, Stanford Center for Biomedical Informatics Research (BMIR), Department of Medicine Stanford University
Lectures
News Type
News
Date
Paragraphs

Liat Clark from Wired writes about REAP's vision care social enterprise, Smart Focus Vision, winning the Clearly Vision Prize for startups that bring low-cost vision care to rural communities around the world. Read the original article here.

Smart Focus Vision

Stanford, CA

The US-based startup has partnered with eyewear company Luxottica OneSight to help scale eye care to ten million people in China that do not have access to affordable services. According to research conducted by Stanford University, only one out of six rural children in China has a set of glasses and most rural students have never had an eye exam. The for-profit ran a pilot operation in conjunction with the Chinese Academy of Sciences before launching in the provinces of Shaanxi and Gansu, where it distributes low-cost glasses, trains doctors and teachers, and constructs clinics. Teachers can test vision directly in classrooms and use mobile phones to automate patient referrals and prescriptions. Smart Focus argues the nonprofit route would never have been a sustainable or scalable way of helping the number of children that need eye care.

As well as a share of the prize money, the winners will have access to mentoring and be invited to a series of one-day events - Clearly Labs - around the globe where they can meet optometrists and other entrepreneurs. The campaign has a number of high-profile advisers onboard, including cofounder of Warby Parker, Neil Blumenthal and founder of Shanghai Tang, David Tang, who commented: "Access to good sight should not be a luxury. Yet, 2.5 billion people are still forced to go without clear vision. Radical new thinking is necessary to rectify this.”

Hero Image
A Chinese girl with glasses provided by Smart Focus, a social enterprise spun out from Stanford and REAP that restores vision to children in rural China.
All News button
1
Subscribe to Health and Medicine